1
2
3
4
Experienced Global Team
Strong, seasoned Management, Board and Scientific Advisory
Dominant Intellectual Property
Broad coverage with over 20 patents and patent applications
Best Treatment & Prophylaxis
Rich pipeline of 9 ART drugs, Pre- and Post-Exposure prophylaxis
Strong Partnering
Co-development, joint venture & financing agreements with 5 partners, 1st MA and launches in 10 countries in 2017-2018